Eisai Brings Halaven To India With A Tiered-Pricing Strategy
This article was originally published in PharmAsia News
Executive Summary
The Japanese drug firm is making a strong bid to make expensive drugs affordable in emerging markets like India. For those who cannot pay, the drug will be made available free of charge.